Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus – Daclizumab – Mycophenolate Mofetil Immune Prophylaxis in Liver Transplantation
2007-003023-20Phase 4Completed
- Sponsor
- Cliniques universitaires Saint-Luc
- Start
- Jun 2008
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, single-arm trial of tacrolimus, daclizumab and mycophenolate mofetil in hepatic failure and hepatic disease, sponsored by Cliniques universitaires Saint-Luc. Primary endpoint: Safety of tacrolimus–daclizumab–mycophenolate mofetil immune prophylaxis. Started Jun 2008; status: completed.
02
Drugs
tacrolimusdaclizumabmycophenolate mofetil
03
Conditions
hepatic failurehepatic disease
Beyond the preview
Go deeper on 2007-003023-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003023-20.